Jazz Pharmaceuticals plc (JAZZ)
Largest Insider Buys in Sector
JAZZ Stock Price History Chart
JAZZ Stock Performance
About Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic and solid tumors. Its lead marketed products include Xyrem, an oral solution for the treatment of cataplexy and excessive daytime sleepiness (EDS) in narcolepsy patients seven years of age and older; Sunosi for the treatment of EDS in patients with narcolepsy and obstructive sleep apnea; Erwinaze to treat acute lymphoblastic leukemia; Defitelio for the treatment of adult and pediatric patients with hepatic veno-occlusive disease; Vyxeos liposome for injection, a product for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia; and Zepzelca for the treatment of adult patients with metastatic small cell lung cancer. The company also offers Xywav, an oxybate product candidate, to treat EDS and cataplexy with narcolepsy and idiopathic hypersomnia; JZP-324, a low sodium oxybate formulation with the potential to provide a clinically meaningful option for narcolepsy patients; JZP385, a T-type calcium channel modulator, for the treatment of essential tremor; JZP458, a recombinant Erwinia asparaginase, for use as a component of a multi-agent chemotherapeutic regimen in the treatment of pediatric and adult patients; and JZP150 for treatment of post-traumatic stress disorder. The company has licensing and collaboration agreements with ImmunoGen, Inc.; Codiak BioSciences, Inc.; Pfenex, Inc.; XL-protein GmbH; and Redx Pharma plc. Jazz Pharmaceuticals plc was incorporated in 2003 and is headquartered in Dublin, Ireland.
Insider Activity of Jazz Pharmaceuticals plc
Over the last 12 months, insiders at Jazz Pharmaceuticals plc have bought $1.44M and sold $3.2M worth of Jazz Pharmaceuticals plc stock.
On average, over the past 5 years, insiders at Jazz Pharmaceuticals plc have bought $3.49M and sold $10.81M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Johnson Philip L (EVP & Chief Financial Officer) — $1.44M.
The last purchase of 12,000 shares for transaction amount of $1.44M was made by Johnson Philip L (EVP & Chief Financial Officer) on 2024‑03‑01.
List of Insider Buy and Sell Transactions, Jazz Pharmaceuticals plc
| 2024-06-07 | Sale | Carr Patricia | SVP, Chief Accounting Officer | 163 0.0003% | $108.83 | $17,738 | -1.45% | |
| 2024-05-03 | Sale | Patil Neena M | EVP & Chief Legal Officer | 5,000 0.008% | $109.65 | $548,250 | -1.01% | |
| 2024-03-07 | Sale | Carr Patricia | SVP, Chief Accounting Officer | 1,768 0.0028% | $116.98 | $206,821 | -4.86% | |
| 2024-03-06 | Sale | Carr Patricia | SVP, Chief Accounting Officer | 1,936 0.0032% | $119.64 | $231,628 | -5.52% | |
| 2024-03-01 | Johnson Philip L | EVP & Chief Financial Officer | 12,000 0.0192% | $119.65 | $1.44M | -6.55% | ||
| 2023-12-04 | Sale | Smith Mark Douglas | director | 417 0.0007% | $119.27 | $49,736 | -2.80% | |
| 2023-12-04 | Sale | Cook Jennifer E. | director | 417 0.0007% | $119.27 | $49,736 | -2.80% | |
| 2023-09-01 | Sale | Patil Neena M | EVP & Chief Legal Officer | 1,500 0.0024% | $144.25 | $216,375 | -15.68% | |
| 2023-08-29 | Sale | Carr Patricia | SVP, Chief Accounting Officer | 142 0.0002% | $143.47 | $20,373 | -15.60% | |
| 2023-08-15 | Sale | Patil Neena M | EVP & Chief Legal Officer | 750 0.0012% | $139.59 | $104,695 | -13.11% | |
| 2023-08-14 | Sale | O'Keefe Kenneth W | director | 1,241 0.0019% | $138.16 | $171,455 | -13.10% | |
| 2023-08-14 | Sale | ENRIGHT PATRICK G | director | 1,241 0.0019% | $138.16 | $171,455 | -13.10% | |
| 2023-08-14 | Sale | McSharry Heather Ann | director | 1,344 0.0021% | $138.16 | $185,685 | -13.10% | |
| 2023-08-14 | Sale | Gray Peter | director | 1,241 0.0019% | $138.16 | $171,455 | -13.10% | |
| 2023-08-14 | Sale | Sohn Catherine A. | director | 1,241 0.0019% | $138.16 | $171,455 | -13.10% | |
| 2023-08-14 | Sale | RIEDEL NORBERT G | director | 1,241 0.0019% | $138.16 | $171,454 | -13.10% | |
| 2023-08-14 | Sale | ORiordan Anne | director | 1,241 0.0019% | $138.16 | $171,454 | -13.10% | |
| 2023-08-14 | Sale | Winningham Rick E | director | 1,241 0.0019% | $138.16 | $171,455 | -13.10% | |
| 2023-08-14 | Sale | Smith Mark Douglas | director | 1,241 0.0019% | $138.16 | $171,454 | -13.10% | |
| 2023-08-14 | Sale | Cook Jennifer E. | director | 1,241 0.0019% | $138.16 | $171,454 | -13.10% |
Insider Historical Profitability
| Patil Neena M | EVP & Chief Legal Officer | 36629 0.0464% | $107.16 | 0 | 7 | |
| Johnson Philip L | EVP & Chief Financial Officer | 27932 0.0448% | $107.16 | 1 | 0 | |
| O'Keefe Kenneth W | director | 24723 0.0393% | $107.16 | 3 | 15 | <0.0001% |
| ENRIGHT PATRICK G | director | 20946 0.0333% | $107.16 | 3 | 47 | +41.08% |
| McSharry Heather Ann | director | 16778 0.0266% | $107.16 | 0 | 10 | |
| Gray Peter | director | 16068 0.0255% | $107.16 | 0 | 9 | |
| Sohn Catherine A. | director | 14868 0.0236% | $107.16 | 0 | 13 | |
| RIEDEL NORBERT G | director | 13705 0.0218% | $107.16 | 0 | 12 | |
| ORiordan Anne | director | 12551 0.0199% | $107.16 | 0 | 3 | |
| Winningham Rick E | director | 10444 0.0166% | $107.16 | 0 | 14 | |
| Cook Jennifer E. | director | 6888 0.0109% | $107.16 | 0 | 5 | |
| Smith Mark Douglas | director | 6888 0.0109% | $107.16 | 0 | 5 | |
| Carr Patricia | SVP, Chief Accounting Officer | 6596 0.0095% | $107.16 | 0 | 26 | |
| KKR JP LLC | 9906501 15.7354% | $107.16 | 1 | 0 | <0.0001% | |
| RAETHER PAUL E | 9906501 15.7354% | $107.16 | 1 | 0 | <0.0001% | |
| MICHELSON MICHAEL W | director | 9906501 15.7354% | $107.16 | 1 | 0 | <0.0001% |
| BRIDGER MANAGEMENT LLC | 10 percent owner | 2667050 4.2363% | $107.16 | 9 | 0 | <0.0001% |
| COLELLA SAMUEL D | director | 1488676 2.3646% | $107.16 | 1 | 0 | <0.0001% |
| TANANBAUM JAMES B | director | 1403129 2.2287% | $107.16 | 1 | 0 | <0.0001% |
| Mulligan Seamus | director | 1152788 1.8311% | $107.16 | 3 | 18 | +20.05% |
| COZADD BRUCE C | Chairman & CEO | 367078 0.5831% | $107.16 | 1 | 100 | +194.39% |
| Saks Samuel R | Chief Executive Officer | 347001 0.5512% | $107.16 | 3 | 0 | <0.0001% |
| MYERS ROBERT M | President | 152206 0.2418% | $107.16 | 1 | 3 | +175.25% |
| FALBERG KATHRYN E | EVP and CFO | 124721 0.1981% | $107.16 | 3 | 9 | +139.43% |
| SEBULSKY ALAN | director | 54355 0.0863% | $107.16 | 2 | 1 | +8.7% |
| Wissel Janne LT | SVP, Chief Regulatory Officer | 47221 0.075% | $107.16 | 0 | 3 | |
| Cox Russell J. | EVP & COO | 47095 0.0748% | $107.16 | 0 | 13 | |
| Hooper Suzanne Sawochka | EVP & General Counsel | 39738 0.0631% | $107.16 | 0 | 26 | |
| Iannone Robert | EVP, Global Head of R&D | 36316 0.0577% | $107.16 | 0 | 1 | |
| Young Matthew P. | EVP & CFO | 36200 0.0575% | $107.16 | 0 | 17 | |
| GALA RENEE D | EVP & Chief Financial Officer | 35978 0.0571% | $107.16 | 0 | 2 | |
| Tobias Jeffrey K | EVP, R&D & CMO | 35063 0.0557% | $107.16 | 0 | 17 | |
| Gamble Carol A | SVP and General Counsel | 32213 0.0512% | $107.16 | 0 | 5 | |
| Keegan Fintan | EVP, Technical Operations | 31750 0.0504% | $107.16 | 0 | 10 | |
| Sablich Kim | EVP, GM of U.S., Commercial Ma | 30560 0.0485% | $107.16 | 0 | 3 | |
| CRESSEY BRYAN C | director | 27631 0.0439% | $107.16 | 1 | 2 | <0.0001% |
| MILLER MICHAEL PATRICK | EVP, US Commercial | 22118 0.0351% | $107.16 | 0 | 40 | |
| Larkin Finbar | SVP, Technical Operations | 21779 0.0346% | $107.16 | 0 | 13 | |
| McGill Iain | SVP, Europe & Rest of World | 20383 0.0324% | $107.16 | 0 | 4 | |
| MOMTAZEE JAMES C | director | 17315 0.0275% | $107.16 | 0 | 1 | |
| Treacy Paul | SVP, Technical Operations | 16418 0.0261% | $107.16 | 0 | 11 | |
| WILSON KAREN J | SVP, Finance & PAO | 15757 0.025% | $107.16 | 0 | 18 | |
| Tovey Christopher J. | EVP, COO & Managing Director E | 14663 0.0233% | $107.16 | 0 | 1 | |
| Smith Karen L. | Global Head of R&D and CMO | 14182 0.0225% | $107.16 | 3 | 0 | <0.0001% |
| Colligan Joan | Principal Accounting Officer | 11384 0.0181% | $107.16 | 0 | 1 | |
| Pearce Samantha | SVP, Head of Europe & Internat | 11309 0.018% | $107.16 | 0 | 9 | |
| BERNS PAUL L | director | 8290 0.0132% | $107.16 | 0 | 11 | |
| Schnee Elmar | director | 8270 0.0131% | $107.16 | 0 | 4 | |
| KKR JP III LLC | 10 percent owner | 7888 0.0125% | $107.16 | 0 | 2 | |
| KKR Fund Holdings L.P. | 10 percent owner | 7888 0.0125% | $107.16 | 0 | 2 | |
| KKR Group Holdings L.P. | 10 percent owner | 0 0% | $107.16 | 0 | 2 | |
| KKR FINANCIAL HOLDINGS III, LLC | 0 0% | $107.16 | 0 | 2 |
Institutional Investor Ownership
| BlackRock | $851.36M | 11.22 | 7.07M | +0.2% | +$1.67M | 0.02 | |
| The Vanguard Group | $776.55M | 10.23 | 6.45M | +1.33% | +$10.23M | 0.02 | |
| State Street | $296.49M | 3.91 | 2.46M | +1.69% | +$4.94M | 0.01 | |
| LSV Asset Management | $286.7M | 3.78 | 2.38M | +1.61% | +$4.53M | 0.6 | |
| JPMorgan Chase | $179.97M | 2.37 | 1.49M | +6.96% | +$11.71M | 0.02 | |
| Polaris Capital Management, LLC | $172.52M | 2.27 | 1.43M | +13.03% | +$19.89M | 8.6 | |
| Capital World Investors | $171.94M | 2.27 | 1.43M | New | +$171.94M | 0.03 | |
| Ameriprise Financial | $164.85M | 2.17 | 1.37M | +4.28% | +$6.76M | 0.05 | |
| Pacer Advisors Inc | $155.79M | 2.05 | 1.29M | +26.38% | +$32.52M | 0.39 | |
| Renaissance Technologies | $140.36M | 1.85 | 1.17M | -5.36% | -$7.95M | 0.22 | |
| Camber Capital Management Lp | $138.48M | 1.82 | 1.15M | +70.37% | +$57.2M | 4.88 | |
| Geode Capital Management | $133.16M | 1.76 | 1.11M | +5.52% | +$6.97M | 0.01 | |
| Fuller & Thaler Asset Management, Inc. | $130.67M | 1.72 | 1.09M | New | +$130.67M | 0.57 | |
| Ecor1 Capital Llc | $122.1M | 1.61 | 1.01M | 0% | +$0 | 3.1 | |
| Fidelity Investments | $115.65M | 1.52 | 960,379 | -21.86% | -$32.35M | 0.01 | |
| Morgan Stanley | $115.5M | 1.52 | 959,105 | +23.15% | +$21.71M | 0.01 | |
| Franklin Templeton Investments | $112.91M | 1.49 | 937,610 | +6.85% | +$7.24M | 0.03 | |
| Baupost Group | $100.39M | 1.32 | 833,696 | 0% | +$0 | 2.83 | |
| Dimensional Fund Advisors | $99.18M | 1.31 | 823,649 | +7.55% | +$6.96M | 0.03 | |
| AQR Capital | $89.67M | 1.18 | 744,646 | +144.72% | +$53.03M | 0.15 | |
| Avidity Partners Management Lp | $70.33M | 0.93 | 584,000 | +19.4% | +$11.43M | 2.55 | |
| Bank of America | $68.39M | 0.9 | 567,962 | +20.72% | +$11.74M | 0.01 | |
| BNY Mellon | $67.53M | 0.89 | 560,795 | -3.31% | -$2.32M | 0.01 | |
| TSW (Thompson, Siegel & Walmsley LLC) | $66.54M | 0.88 | 552,573 | +56.73% | +$24.09M | 1.05 | |
| Northern Trust | $65.66M | 0.87 | 545,285 | -10.45% | -$7.66M | 0.01 | |
| Perpetual Limited | $57.2M | 0.75 | 475,018 | +53.99% | +$20.06M | 0.57 | |
| Charles Schwab | $55.39M | 0.73 | 459,944 | -9.04% | -$5.5M | 0.01 | |
| Legal & General | $53.56M | 0.71 | 444,819 | -6.28% | -$3.59M | 0.01 | |
| Nuveen | $53.41M | 0.7 | 443,531 | +61.34% | +$20.3M | 0.02 | |
| Brandywine Global Investment Management | $52.57M | 0.69 | 436,557 | +13.68% | +$6.33M | 0.38 | |
| Invesco | $46M | 0.61 | 381,956 | -0.57% | -$265,887.36 | 0.01 | |
| GW&K Investment Management | $43.8M | 0.58 | 363,746 | -0.85% | -$375,596.04 | 0.39 | |
| The Manufacturers Life Insurance Company | $42.5M | 0.56 | 352,944 | +26.31% | +$8.85M | 0.04 | |
| CalPERS | $37.35M | 0.49 | 310,125 | +11.44% | +$3.83M | 0.03 | |
| Robeco Institutional Asset Management B.V. | $36.62M | 0.48 | 304,110 | -2.41% | -$906,040.05 | 0.08 | |
| KBC Group | $35.89M | 0.47 | 298,056 | +81.9% | +$16.16M | 0.11 | |
| Marshall Wace | $32.29M | 0.43 | 268,124 | +817.13% | +$28.77M | 0.04 | |
| Russell Investments Group Ltd | $31.85M | 0.42 | 264,473 | +8.79% | +$2.57M | 0.05 | |
| Todd Asset Management Llc | $29.33M | 0.39 | 243,580 | +43.09% | +$8.83M | 0.6 | |
| Ubs Asset Management Americas Inc | $29.1M | 0.38 | 241,685 | +3.78% | +$1.06M | 0.01 | |
| Systematic Financial Management LLC | $28.98M | 0.38 | 240,679 | +21.41% | +$5.11M | 0.82 | |
| Wellington Management Company | $28.16M | 0.37 | 233,818 | -81.74% | -$126M | 0.01 | |
| Wells Fargo | $26.78M | 0.35 | 222,358 | +100.22% | +$13.4M | 0.01 | |
| D. E. Shaw & Co. | $25M | 0.33 | 207,601 | -18.2% | -$5.56M | 0.03 | |
| Los Angeles Capital Management LLC | $24.24M | 0.32 | 201,261 | -34.95% | -$13.02M | 0.08 | |
| Samlyn Capital, LLC | $23.83M | 0.31 | 197,925 | -68.19% | -$51.09M | 0.42 | |
| Aristotle | $23.71M | 0.31 | 196,943 | -0.13% | -$31,424.53 | 0.05 | |
| Retirement Systems of Alabama | $23.38M | 0.31 | 194,119 | +12.24% | +$2.55M | 0.09 | |
| Grantham Mayo Van Otterloo & Co LLC | $23.39M | 0.31 | 194,200 | -6.53% | -$1.63M | 0.09 | |
| Goldman Sachs | $22.44M | 0.3 | 186,364 | -21.87% | -$6.28M | <0.01 |